Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Upfront DPYD Genotyping and Toxicity Associated with Fluoropyrimidine-Based Concurrent Chemoradiotherapy for Oropharyngeal Carcinomas: A Work in Progress.
Desilets A, McCarvill W, Aubin F, Bahig H, Ballivy O, Charpentier D, Filion É, Jamal R, Lambert L, Nguyen-Tan PF, Vadnais C, Weng X, Soulières D. Desilets A, et al. Among authors: charpentier d. Curr Oncol. 2022 Jan 26;29(2):497-509. doi: 10.3390/curroncol29020045. Curr Oncol. 2022. PMID: 35200545 Free PMC article.
Phase II multicenter trial with carboplatin and gemcitabine induction chemotherapy followed by radiotherapy concomitantly with low-dose paclitaxel and gemcitabine for stage IIIA and IIIB non-small cell lung cancer.
Hirsh V, Soulieres D, Duclos M, Faria S, Del Vecchio P, Ofiara L, Ayoub JP, Charpentier D, Gruber J, Portelance L, Souhami L. Hirsh V, et al. Among authors: charpentier d. J Thorac Oncol. 2007 Oct;2(10):927-32. doi: 10.1097/JTO.0b013e3181560b92. J Thorac Oncol. 2007. PMID: 17909355 Free article. Clinical Trial.
Concurrent chemoradiation with carboplatin-5-fluorouracil versus cisplatin in locally advanced oropharyngeal cancers: is more always better?
Barkati M, Fortin B, Soulières D, Clavel S, Després P, Charpentier D, Tabet JC, Guertin L, Olivier MJ, Coulombe G, Donath D, Nguyen-Tan PF. Barkati M, et al. Among authors: charpentier d. Int J Radiat Oncol Biol Phys. 2010 Feb 1;76(2):410-6. doi: 10.1016/j.ijrobp.2009.02.034. Epub 2009 May 8. Int J Radiat Oncol Biol Phys. 2010. PMID: 19427745
Enteral feeding during chemoradiotherapy for advanced head-and-neck cancer: a single-institution experience using a reactive approach.
Clavel S, Fortin B, Després P, Donath D, Soulières D, Khaouam N, Charpentier D, Bélair M, Guertin L, Nguyen-Tan PF. Clavel S, et al. Among authors: charpentier d. Int J Radiat Oncol Biol Phys. 2011 Mar 1;79(3):763-9. doi: 10.1016/j.ijrobp.2009.12.032. Epub 2010 May 24. Int J Radiat Oncol Biol Phys. 2011. PMID: 20510546
Phase I/II trial of Durvalumab plus Tremelimumab and stereotactic body radiotherapy for metastatic head and neck carcinoma.
Bahig H, Aubin F, Stagg J, Gologan O, Ballivy O, Bissada E, Nguyen-Tan FP, Soulières D, Guertin L, Filion E, Christopoulos A, Lambert L, Tehfe M, Ayad T, Charpentier D, Jamal R, Wong P. Bahig H, et al. Among authors: charpentier d. BMC Cancer. 2019 Jan 14;19(1):68. doi: 10.1186/s12885-019-5266-4. BMC Cancer. 2019. PMID: 30642290 Free PMC article. Clinical Trial.
65 results